Stock overview
I-Mab - US ADR
Explore the company, reported ownership, price history, and available source evidence.
I-Mab is a clinical-stage biotech developing immunotherapy treatments for cancer.
- Last close
- $1.20
- · NBP
- Tracked holders
- 1 fund
- Latest available 13F per fund
NBP · USD
Price
$1.20
-$0.17
(-12.45%)
over selected range
Close · Oct 30, 2026
Market closed
23 stored daily closes
$1.20
Oct 30, 2026
- Range low
- $1.20
- Range high
- $1.43
- Observations
- 23
- Session date
- Oct 30, 2026
Sep 30, 2026–Oct 30, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q2 2026 · filed Aug 13, 2026 · SEC filing | +178% 26'Q2 | $1,478,541 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market